BR0014880A - Composição farmacêutica aquosa contendo ciclosonida - Google Patents

Composição farmacêutica aquosa contendo ciclosonida

Info

Publication number
BR0014880A
BR0014880A BR0014880-6A BR0014880A BR0014880A BR 0014880 A BR0014880 A BR 0014880A BR 0014880 A BR0014880 A BR 0014880A BR 0014880 A BR0014880 A BR 0014880A
Authority
BR
Brazil
Prior art keywords
cyclosonide
pharmaceutical composition
composition containing
aqueous pharmaceutical
preventing
Prior art date
Application number
BR0014880-6A
Other languages
English (en)
Other versions
BRPI0014880B8 (pt
BRPI0014880B1 (pt
Inventor
Atsuhiro Nagano
Yoshihisa Nishibe
Kazuya Takanashi
Original Assignee
Byk Gulden Lomberg Chem Fab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=17856339&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=BR0014880(A) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Byk Gulden Lomberg Chem Fab filed Critical Byk Gulden Lomberg Chem Fab
Publication of BR0014880A publication Critical patent/BR0014880A/pt
Publication of BRPI0014880B1 publication Critical patent/BRPI0014880B1/pt
Publication of BRPI0014880B8 publication Critical patent/BRPI0014880B8/pt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/58—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids containing heterocyclic rings, e.g. danazol, stanozolol, pancuronium or digitogenin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A61K31/14—Quaternary ammonium compounds, e.g. edrophonium, choline
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
    • A61K47/38—Cellulose; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/141—Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers
    • A61K9/146—Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers with organic macromolecular compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/38—Drugs for disorders of the endocrine system of the suprarenal hormones
    • A61P5/44—Glucocorticosteroids; Drugs increasing or potentiating the activity of glucocorticosteroids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/38—Drugs for disorders of the endocrine system of the suprarenal hormones
    • A61P5/46—Drugs for disorders of the endocrine system of the suprarenal hormones for decreasing, blocking or antagonising the activity of glucocorticosteroids

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Inorganic Chemistry (AREA)
  • Diabetes (AREA)
  • Endocrinology (AREA)
  • Pulmonology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

Abstract

"COMPOSIçãO FARMACêUTICA AQUOSA CONTENDO CICLOSONIDA". A presente invenção fornece uma composição farmacêutica aquosa contendo ciclosonida e hidroxipropilmetilcelulose, onde a ciclosonida é dispersa em um veículo aquoso na forma de partículas sólidas. A composição é capaz de evitar variações nas concentrações de ciclosonida durante a produção bem como evitar a diminuição na taxa de recuperação de ciclosonida.
BRPI0014880A 1999-10-20 2000-10-20 composição farmacêutica aquosa contendo ciclosonida BRPI0014880B8 (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP29818699 1999-10-20
PCT/JP2000/007351 WO2001028563A1 (en) 1999-10-20 2000-10-20 Ciclesonide-containing aqueous pharmaceutical composition

Publications (3)

Publication Number Publication Date
BR0014880A true BR0014880A (pt) 2002-06-11
BRPI0014880B1 BRPI0014880B1 (pt) 2015-08-11
BRPI0014880B8 BRPI0014880B8 (pt) 2021-05-25

Family

ID=17856339

Family Applications (1)

Application Number Title Priority Date Filing Date
BRPI0014880A BRPI0014880B8 (pt) 1999-10-20 2000-10-20 composição farmacêutica aquosa contendo ciclosonida

Country Status (35)

Country Link
US (2) US8383611B1 (pt)
EP (1) EP1227817B1 (pt)
JP (1) JP4856338B2 (pt)
KR (1) KR100705372B1 (pt)
CN (1) CN1198623C (pt)
AR (1) AR026073A1 (pt)
AT (1) ATE270107T1 (pt)
AU (1) AU776587B2 (pt)
BG (1) BG65799B1 (pt)
BR (1) BRPI0014880B8 (pt)
CA (1) CA2388325C (pt)
CO (1) CO5251406A1 (pt)
CZ (1) CZ297780B6 (pt)
DE (1) DE60011924T2 (pt)
DK (1) DK1227817T3 (pt)
EA (1) EA005201B1 (pt)
ES (1) ES2223595T3 (pt)
HR (1) HRP20020345B1 (pt)
HU (1) HU228894B1 (pt)
IL (2) IL148725A0 (pt)
ME (1) ME00568B (pt)
MX (1) MXPA02003975A (pt)
MY (1) MY121175A (pt)
NO (1) NO327379B1 (pt)
NZ (1) NZ518299A (pt)
PE (1) PE20010713A1 (pt)
PL (1) PL197537B1 (pt)
PT (1) PT1227817E (pt)
RS (1) RS50345B (pt)
SI (1) SI1227817T1 (pt)
SK (1) SK286194B6 (pt)
TR (1) TR200200831T2 (pt)
TW (1) TWI269655B (pt)
WO (1) WO2001028563A1 (pt)
ZA (1) ZA200203078B (pt)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AR026073A1 (es) * 1999-10-20 2002-12-26 Nycomed Gmbh Composicion farmaceutica acuosa que contiene ciclesonida
BRPI0312377A8 (pt) * 2002-07-02 2015-12-15 Altana Pharma Ag Suspensão aquosa estéril contendo ciclesonida
DE60333205D1 (de) 2002-08-30 2010-08-12 Nycomed Gmbh Histaminika zur behandlung von allergischer rhinitis
ES2312844T3 (es) 2002-12-12 2009-03-01 Nycomed Gmbh Medicamento de combinacion de r, r-formoterol y ciclesonida.
MY143936A (en) 2003-03-27 2011-07-29 Nycomed Gmbh Process for preparing crystalline ciclesonide with defined particle size
AU2004271744B2 (en) 2003-09-16 2010-07-29 Covis Pharma B.V. Use of ciclesonide for the treatment of respiratory diseases
PE20050941A1 (es) 2003-12-16 2005-11-08 Nycomed Gmbh Suspensiones acuosas de ciclesonida para nebulizacion
EP1827378A2 (en) * 2004-11-17 2007-09-05 Government of The United States of America, as represented by Secretary, Department of Health and Human Services Steroid formulation and methods of treatment using same
JP5661985B2 (ja) 2006-12-27 2015-01-28 帝人ファーマ株式会社 無菌性水性懸濁製剤
EP2262506B1 (en) 2008-03-11 2014-05-07 Alcon Research, Ltd. Low viscosity, highly flocculated triamcinolone acetonide suspensions for intravitreal injection
US11007150B2 (en) 2011-08-18 2021-05-18 Covis Pharma Gmbh Pharmaceutical aerosol product for administration by oral or nasal inhalation

Family Cites Families (58)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4271143A (en) 1978-01-25 1981-06-02 Alcon Laboratories, Inc. Sustained release ophthalmic drug dosage
CH657779A5 (de) 1982-10-05 1986-09-30 Sandoz Ag Galenische zusammensetzungen enthaltend calcitonin.
IL70489A0 (en) 1982-12-29 1984-03-30 Armour Pharma Pharmaceutical compositions containing calcitonin
JPS59163313A (ja) 1983-03-09 1984-09-14 Teijin Ltd 経鼻投与用ペプチドホルモン類組成物
AU565354B2 (en) 1983-11-14 1987-09-10 Bio-Mimetics Inc. Bioadhesive compositions and methods of treatment therewith
GB8515132D0 (en) 1985-06-14 1985-07-17 British Nuclear Fuels Plc Measuring photosynthetic activities of plants
US5179079A (en) 1986-12-16 1993-01-12 Novo Nordisk A/S Nasal formulation and intranasal administration therewith
MY102411A (en) 1986-12-23 1992-06-17 Ciba Geigy Ag Nasal solutions
JPH0744940B2 (ja) 1986-12-24 1995-05-17 ライオン株式会社 口腔貼付用基材
US4802967A (en) 1987-04-08 1989-02-07 Andus Corporation Surface treatment of polymers
JPS63303931A (ja) 1987-06-05 1988-12-12 Sumitomo Pharmaceut Co Ltd 経鼻投与用成長ホルモン放出活性物質製剤
US4788220A (en) 1987-07-08 1988-11-29 American Home Products Corporation (Del.) Pediatric ibuprofen compositions
US5192535A (en) 1988-02-08 1993-03-09 Insite Vision Incorporated Ophthalmic suspensions
US5188826A (en) 1988-02-08 1993-02-23 Insite Vision Incorporated Topical ophthalmic suspensions
US5776493A (en) 1989-07-14 1998-07-07 Alza Corporation Oral osmotic device for delivery of nystatin with hydrogel driving member
ATE113841T1 (de) 1989-10-31 1994-11-15 Columbia Lab Inc Mittel zur feuchthaltung vaginalen gewebes.
US5147654A (en) 1990-07-23 1992-09-15 Alza Corporation Oral osmotic device for delivering nicotine
JPH078806B2 (ja) 1990-08-16 1995-02-01 旭化成工業株式会社 カルシトニン類含有経鼻投与用乳剤
GB9102579D0 (en) 1991-01-24 1991-03-27 Glaxo Group Ltd Compositions
GB9103824D0 (en) 1991-02-23 1991-04-10 Fisons Ag Formulation
EP0578780B1 (en) 1991-04-03 2003-07-02 Keimowitz, Rudolph, M.D. Suppression of thromboxane levels by percutaneous administration of aspirin
IT1250691B (it) * 1991-07-22 1995-04-21 Giancarlo Santus Composizioni terapeutiche per somministrazione intranasale comprendenti ketorolac.
US5200195A (en) 1991-12-06 1993-04-06 Alza Corporation Process for improving dosage form delivery kinetics
JP2860729B2 (ja) 1992-03-10 1999-02-24 エスエス製薬株式会社 プラノプロフェン懸濁シロップ剤
CA2101126A1 (en) 1992-08-03 1994-02-04 Yasushi Morita Preparation for local treatment
JP3047948B2 (ja) 1992-12-07 2000-06-05 株式会社ツムラ ペプチド類経鼻投与用組成物
US5340572A (en) 1993-02-08 1994-08-23 Insite Vision Incorporated Alkaline ophthalmic suspensions
US5409703A (en) 1993-06-24 1995-04-25 Carrington Laboratories, Inc. Dried hydrogel from hydrophilic-hygroscopic polymer
JP2787131B2 (ja) 1993-07-30 1998-08-13 千寿製薬株式会社 水性懸濁液剤
US5540930A (en) 1993-10-25 1996-07-30 Pharmos Corporation Suspension of loteprednol etabonate for ear, eye, or nose treatment
JP3781792B2 (ja) 1993-12-27 2006-05-31 千寿製薬株式会社 ジフルプレドナート含有点眼用懸濁液剤
JPH07188059A (ja) 1993-12-28 1995-07-25 Rohto Pharmaceut Co Ltd 歯周病治療剤
RU2102979C1 (ru) 1994-07-18 1998-01-27 Панкрушева Татьяна Александровна Средство для лечения гнойно-воспалительных процессов кожи и слизистых оболочек различной этиологии
US5726181A (en) 1995-06-05 1998-03-10 Bionumerik Pharmaceuticals, Inc. Formulations and compositions of poorly water soluble camptothecin derivatives
AU6392496A (en) 1995-06-29 1997-01-30 Mcneil-Ppc, Inc. The combination of topical nasal antihistamines and topical nasal steroids
JP3098401B2 (ja) 1995-07-12 2000-10-16 株式会社エルティーティー研究所 経鼻投与用製剤
JP2791317B2 (ja) 1995-12-26 1998-08-27 株式会社三和化学研究所 多層フィルム製剤
ATE247456T1 (de) 1996-02-27 2003-09-15 Teijin Ltd Puderförmige zusammensetzung zur nasalen anwendung
US5976573A (en) 1996-07-03 1999-11-02 Rorer Pharmaceutical Products Inc. Aqueous-based pharmaceutical composition
US5955097A (en) 1996-10-18 1999-09-21 Virotex Corporation Pharmaceutical preparation applicable to mucosal surfaces and body tissues
IT1286496B1 (it) 1996-11-20 1998-07-15 Leetrim Ltd Dublin Composizione farmaceutica orale ad attivita' antipiretica,analgesica ed antiinfiammatoria
FR2756739B1 (fr) 1996-12-05 2000-04-28 Astra Ab Nouvelle formulation de budesonide
SE9604486D0 (sv) 1996-12-05 1996-12-05 Astra Ab Novel formulation
TW503113B (en) 1997-01-16 2002-09-21 Senju Pharma Co Aqueous suspension for nasal administration
US6120752A (en) 1997-05-21 2000-09-19 3M Innovative Properties Company Medicinal aerosol products containing formulations of ciclesonide and related steroids
JPH1121229A (ja) 1997-06-30 1999-01-26 Kyoto Yakuhin Kogyo Kk 抗真菌性外用製剤およびその製造方法
JPH11130658A (ja) 1997-10-30 1999-05-18 Teijin Ltd 水性懸濁医薬品組成物
JP3386348B2 (ja) 1997-10-30 2003-03-17 帝人株式会社 鼻腔内投与用水性懸濁製剤
JP3386349B2 (ja) 1997-10-30 2003-03-17 帝人株式会社 水性懸濁医薬品組成物
SE9704186D0 (sv) 1997-11-14 1997-11-14 Astra Ab New composition of matter
KR100683510B1 (ko) 1998-01-22 2007-02-16 산텐 세이야꾸 가부시키가이샤 플루오로메톨론 현탁형 점안제
SE514128C2 (sv) 1998-03-17 2001-01-08 Pharmalink Ab Användning av en glukokortikoid för framställning av ett läkemedel för behandling av glomerulonefrit
TWI243687B (en) 1998-04-21 2005-11-21 Teijin Ltd Pharmaceutical composition for application to mucosa
US6124268A (en) * 1999-02-17 2000-09-26 Natreon Inc. Natural antioxidant compositions, method for obtaining same and cosmetic, pharmaceutical and nutritional formulations thereof
RU11829U1 (ru) 1999-05-05 1999-11-16 Специальное конструкторское бюро транспортного машиностроения (ОАО Спецмаш) Рабочая площадка для буровых установок
AR026073A1 (es) * 1999-10-20 2002-12-26 Nycomed Gmbh Composicion farmaceutica acuosa que contiene ciclesonida
AR026072A1 (es) 1999-10-20 2002-12-26 Nycomed Gmbh Composicion farmaceutica que contiene ciclesonida para aplicacion a la mucosa
AU7947600A (en) 1999-10-20 2001-04-30 Teijin Limited Aqueous medicinal compositions

Also Published As

Publication number Publication date
WO2001028563A1 (en) 2001-04-26
RS50345B (sr) 2009-11-10
CA2388325C (en) 2007-09-18
BRPI0014880B8 (pt) 2021-05-25
HK1051003A1 (en) 2003-07-18
CZ20021284A3 (cs) 2002-07-17
NO20021866D0 (no) 2002-04-19
ES2223595T3 (es) 2005-03-01
PL197537B1 (pl) 2008-04-30
NO20021866L (no) 2002-04-19
EP1227817A1 (en) 2002-08-07
IL148725A0 (en) 2002-09-12
SK6932002A3 (en) 2002-09-10
DK1227817T3 (da) 2004-11-15
BG65799B1 (bg) 2009-12-31
MY121175A (en) 2005-12-30
HUP0203756A2 (en) 2003-05-28
YU28102A (sh) 2004-12-31
MXPA02003975A (es) 2003-09-25
BG106517A (en) 2002-12-29
ME00568A (en) 2011-12-20
EA200200383A1 (ru) 2002-10-31
BRPI0014880B1 (pt) 2015-08-11
TWI269655B (en) 2007-01-01
ATE270107T1 (de) 2004-07-15
JP4856338B2 (ja) 2012-01-18
KR20020060205A (ko) 2002-07-16
SI1227817T1 (en) 2004-12-31
SK286194B6 (sk) 2008-05-06
CA2388325A1 (en) 2001-04-26
PT1227817E (pt) 2004-11-30
JP2003512330A (ja) 2003-04-02
US8383611B1 (en) 2013-02-26
AR026073A1 (es) 2002-12-26
CO5251406A1 (es) 2003-02-28
ME00568B (me) 2011-12-20
NZ518299A (en) 2004-03-26
CN1198623C (zh) 2005-04-27
AU7953200A (en) 2001-04-30
HUP0203756A3 (en) 2004-06-28
EP1227817B1 (en) 2004-06-30
HRP20020345A2 (en) 2005-10-31
ZA200203078B (en) 2003-01-29
EA005201B1 (ru) 2004-12-30
CN1379673A (zh) 2002-11-13
HU228894B1 (hu) 2013-06-28
IL148725A (en) 2006-12-31
PE20010713A1 (es) 2001-07-13
TR200200831T2 (tr) 2002-07-22
KR100705372B1 (ko) 2007-04-11
PL356190A1 (en) 2004-06-14
NO327379B1 (no) 2009-06-22
AU776587B2 (en) 2004-09-16
US20130095146A1 (en) 2013-04-18
DE60011924D1 (de) 2004-08-05
HRP20020345B1 (en) 2006-12-31
DE60011924T2 (de) 2005-07-07
CZ297780B6 (cs) 2007-03-28

Similar Documents

Publication Publication Date Title
BR0014880A (pt) Composição farmacêutica aquosa contendo ciclosonida
IS6344A (is) Lyfjasamsetningar sem leiða til aukinna lyfjastyrkja
DE60319925D1 (de) Verringerung des Ausflusses von Partikeln in Bohrlöchern
DK1459737T3 (da) Granulat indeholdende syreustabilt kemisk middel i stor mængde
DE60329490D1 (de) Dispersionen von silikonen
EP1582206A4 (en) WATER-SOLUBLE COMPOSITION WITH COENZYM Q10
CY1108682T1 (el) Διασφαλισμενη εναντια σε καταχρηση μορφη χορηγησης
HRP20041152B1 (hr) Farmaceutske formulacije
HRP20020198B1 (hr) Formulacija moksifloksacina i kuhinjske soli
MXPA04001328A (es) Productos en combinacion de derivados de 1,4-benzotiepina-1,1-dioxido con otros ingredientes activos, y su uso.
DE60134274D1 (en) Complex enthaltend modafinil und cyclodextrin
DE50301661D1 (de) Darreichungsform von Ibuprofen-Natrium
IS5851A (is) Ný lyf til inntöku 5-HT4 gerandefna eða mótlyfja
NO20021409L (no) Hastighets-kontrollerte partikler
AU311848S (en) Pleated face mask
ATE372814T1 (de) Filtervorrichtung zum schutz gegen biologische wirkstoffe
AU2003273843A8 (en) Use of skin-protecting substances
EP1666445A4 (en) CRYSTAL OF REDUCED COENZYME Q10 WITH EXCELLENT STABILITY AND COMPOSITION CONTAINING THE CRYSTAL OF REDUCED COENZYME Q10
AR020695A1 (es) Metodos para controlar macroinvertebrados en sistemas acuosos
NO20024363D0 (no) Nye LHRH-antagonister, produksjon og anvendelse av disse som medikamant
EE04623B1 (et) Ühendusdetail
NO20055882L (no) Farmasoytiske formuleringer omfattende amoksicillin og klavulanat
TW200509990A (en) Pharmaceutical formulations
AR051412A1 (es) Suspensiones farmaceuticas exentas de colorantes y metodods relacionados
DK1369122T3 (da) Anticancermiddel

Legal Events

Date Code Title Description
B25D Requested change of name of applicant approved
B25D Requested change of name of applicant approved

Owner name: NYCOMED GMBH (DE)

Free format text: ALTERADO DE: ALTANA PHARMA AG

B07A Application suspended after technical examination (opinion) [chapter 7.1 patent gazette]
B09B Patent application refused [chapter 9.2 patent gazette]

Free format text: INDEFIRO O PEDIDO DE ACORDO COM O(S) ARTIGO(S)8O E 13 DA LPI

B12B Appeal against refusal [chapter 12.2 patent gazette]
B25D Requested change of name of applicant approved

Owner name: TAKEDA GMBH (DE)

B07D Technical examination (opinion) related to article 229 of industrial property law [chapter 7.4 patent gazette]
B07E Notification of approval relating to section 229 industrial property law [chapter 7.5 patent gazette]

Free format text: NOTIFICACAO DE ANUENCIA RELACIONADA COM O ART 229 DA LPI

B16A Patent or certificate of addition of invention granted [chapter 16.1 patent gazette]

Free format text: PRAZO DE VALIDADE: 10 (DEZ) ANOS CONTADOS A PARTIR DE 11/08/2015, OBSERVADAS AS CONDICOES LEGAIS.

B25A Requested transfer of rights approved
B25A Requested transfer of rights approved
B25D Requested change of name of applicant approved
B25A Requested transfer of rights approved
B25A Requested transfer of rights approved
B16C Correction of notification of the grant [chapter 16.3 patent gazette]

Free format text: PRAZO DE VALIDADE: 20 (VINTE) ANOS CONTADOS A PARTIR DE 20/10/2000 OBSERVADAS AS CONDICOES LEGAIS. PATENTE CONCEDIDA CONFORME ADI 5.529/DF

B21A Patent or certificate of addition expired [chapter 21.1 patent gazette]

Free format text: PATENTE EXTINTA EM 20/10/2020